Emcure Pharma Plans Rs 4,000 Crore IPO
Sinhaajay397@gmail.c05 Oct, 2021News
Pune-based Emcure Pharmaceuticals Limited, the 12th largest pharmaceutical company in India, has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) for its initial public offering (IPO). Market sources say the company is planning an IPO for about Rs 4,000 crore, though it hasn't finalised the date of launching the issue. The IPO will include a fresh issue of equity shares aggregating up to Rs 1,100 crores and an offer for sale aggregating up to 18,168,356 equity shares from the promoters. This includes promoters Satish Mehta selling upto 2,030,000 equity shares and Sunil Mehta aggregating upto 2,50,000 equity shares. Other selling shareholders include private equity investor Bain Capital. Private equity firm Bain Capital owns about 13% stake in Emcure.
Related Bookmarks
- Order Chicken Methi Malai in Noida
- IPO: Bain Capital-Backed Emcure Pharma Looks To List
- Best Cryptocurrency Guest Posting Service
- High Performance Insulation materials and their Key Issues and thermal properties
- Clicking here
- Saudi Arabia look to banish memories of humiliating loss to Japan 10 years ago
- Fixed: ‘A Name Has Not Been Set for This Account YouTube’ Error
- IATA annual meet debates cargo future; Qatar Airways double cargo earnings in 2020-21
- WFS to digitise EMEAA operations with CHAMP solution
- Order Mutton Keema in Noida
Recent Profiles
The Thompson Group
Adelaide Towing Top Cash For Cars
Garden And Tree Men
Tuyen Giao Thu Do
Law Offices Of J.b. Katz, P.c.
Munster Distinctive Dentistry,llc & Orthodontics
Wassup Australia
Girlsjewelry
Pelican55
Sym House